Spheris Reports Fourth Quarter and Year-End 20...(made from time totime by the Company wit...),Health

Date:3/26/2008

made from time to time by the Company with the Securities and Exchange Commission, including, without limitation, the following: (i) the effect our substantial indebtedness has on our ability to raise additional capital to fund our business, to react to changes in the economy or our business and to fulfill our obligations under our indebtedness, including our senior secured credit facility and indenture relating to our senior subordinated notes; (ii) our history of losses and accumulated deficit; (iii) our ability to effectively manage our global production capacity, including our ability to recruit, train and retain qualified medical language specialists and maintain high standards of quality service in our operations; (iv) our ability to adapt and integrate new technology into our clinical documentation platforms to improve our production capabilities and expand the breadth of our technology and service offerings; (v) our ability to maintain our competitive position against current and future competitors, including our ability to gain new business with acceptable operating margins and ongoing price pressures related to our technology and services and the healthcare market in general; (vi) the reluctance of potential customers to outsource or change providers of their clinical documentation technology and services and its impact on our ability to attract new customers and increase revenues; (vii) financial and operational risks inherent in our global operations, including foreign currency exchange rate fluctuations and transfer pricing laws between the United States and India; (viii) our ability to attract, hire and retain skilled technical and managerial personnel necessary to develop and implement technology and services to our customers; (ix) the effect on our business if we incur additional debt, contingent liabilities and expenses in connection with future acquisitions or if we cannot effectively integrate newly acquired operations; and (x) our ability to ade
'/>"/>

SOURCE Spheris Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11
Related medicine news :

1. Spheris Sets Fourth Quarter 2007 Earnings Release and Conference Call Dates
2. Spheris Elects New Board Member
3. NeurogesX Reports Fourth Quarter and Year-End 2007 Financial Results
4. QMed, Inc. Reports Year-End and Fourth Quarter Results
5. Pelosi Statement on Social Security and Medicare Trustees Reports
6. NASI Experts Available to Comment on 2008 Social Security and Medicare Trustees Reports
7. SPO Medical Reports 2007 Sales: Growth of 35% Compared to 2006
8. Ardea Biosciences Reports Progress of Clinical Development Programs; Provides 2008 Outlook; Announces 2007 Financial Results and Provides 2008 Financial Guidance
9. U.S. Army Study Reports WoundStat(TM) is Most Effective
10. CryoCor Reports 2007 Results
11. IPC The Hospitalist Company Reports Fourth Quarter and Full Year 2007 Results